Ecolab Inc.

What they do

Ecolab operates through four reportable segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. It provides water treatment, cleaning and sanitizing, pest elimination, and life sciences solutions. The company serves industries including food and beverage, healthcare, data centers, microelectronics, and hospitality.

Revenue drivers

• Global Water — Largest segment, includes Heavy Water, Light Water, High-Tech, Food & Beverage, and Paper. Q2 2026 organic sales grew 4% to $2.1 billion.
• Global Institutional & Specialty — Provides cleaning and sanitizing products to institutional (hospitals, hotels) and specialty markets. Q2 2026 organic sales grew 4% to $1.6 billion.
• Global Pest Elimination — Pest control services for commercial customers. Q2 2026 organic sales grew 7% to $345.2 million.
• Global Life Sciences — Supplies solutions for pharmaceutical and biopharma industries. Q2 2026 organic sales accelerated 15% to $221.0 million.

Recent performance

In Q2 2026, reported net sales increased 10% to $4.4 billion and organic sales grew 5%. Reported diluted EPS was $1.90, up 3%, while adjusted diluted EPS increased 11% to $2.09. Reported operating income rose 7% to $757.9 million, and adjusted operating income increased 10%. For full-year 2025, revenue was $16.08 billion and net income was $2.08 billion.

Strategy

Ecolab pursues a 'One Ecolab' enterprise selling strategy to cross-sell across segments. Management emphasizes innovation in water, hygiene, and AI-technology solutions. Recent acquisitions, Ovivo Electronics ($1.6B) and CoolIT, expand its High-Tech growth engine, targeting AI infrastructure. The company aims to conserve 300 billion gallons of water annually by 2030.

Risks

• Commodity cost inflation — Rising commodity costs pressure margins; management implemented an energy surcharge to offset, but effectiveness is uncertain.
• Middle East disruptions — Customer operations disrupted by conflict in the Middle East, creating a near 1% headwind to reported volume growth in Q2 2026.
• Acquisition integration — Integration of Ovivo Electronics and CoolIT may incur higher costs or fail to achieve expected growth, impacting financials.
• Foreign currency fluctuation — International operations expose results to currency translation effects; for Q2 2026, foreign currency translation reduced reported sales by $11.0 million.

Outlook

For 2026, management raised adjusted diluted EPS guidance to $8.05-$8.25, representing 7%-10% growth. For Q3 2026, adjusted diluted EPS is expected in the range of $2.13-$2.23, up 3%-8%. The outlook includes a short-term impact from non-cash amortization and financing costs of the CoolIT acquisition.